Protocol of a case-control longitudinal study (fraXity) assessing frailty and complexity among Swiss home service recipients using interRAI-HC assessments

BMC Geriatrics
Catherine Ludwig, Catherine Busnel

Abstract

The early screening of frail individuals and of patients with complex care needs are challenges that countries witnessing population aging face. Homecare nurses are actors of choice in meeting these challenges, yet they need means of identifying frail and complex patients in their routine practice. The fraXity study's aim is to fill this gap by (1) proposing frailty and complexity computation algorithms derived from the interRAI-HC; (2) assessing the predictive validity of the proposed indices with respect to adverse health outcomes; and (3) identifying subgroups of the aged population for whom the early screening of frailty and complexity appears to be most relevant. The study will rely on a prospective observational case-control longitudinal study. Three samples of individuals aged 65 or older living in the community will be considered: recipients of formal home care (case 1), of formal home assistance (case 2) and individuals free of formal home services (controls). All participants will receive interRAI-HC assessments at three measurement occasions, separated by six-month intervals. Baseline assessments will serve to derive frailty and complexity scores. Follow-ups will serve to assess the predictive validity of the propose...Continue Reading

Associated Clinical Trials

References

Aug 1, 1997·Journal of the American Geriatrics Society·J N MorrisE Topinková
May 31, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L Z RubensteinB Vellas
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Jan 30, 2004·The American Journal of Medicine·Mary E Tinetti, Terri Fried
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
Jul 18, 2006·The Medical Clinics of North America·Peter de JongeFriedrich C Stiefel
Oct 2, 2008·BMC Geriatrics·Samuel D SearleKenneth Rockwood
Apr 3, 2009·The New England Journal of Medicine·Stephen F JencksEric A Coleman
May 1, 2009·BMC Health Services Research·Leonard C GrayJohn N Morris
Oct 6, 2009·Lancet·Kaare ChristensenJames W Vaupel
Aug 23, 2012·Journal of Clinical Epidemiology·Nathan D ShippeeVictor M Montori
Jun 15, 2013·Journal of the American Medical Directors Association·John E MorleyJeremy Walston
Oct 29, 2013·Annual Review of Medicine·Sunil KripalaniEduard E Vasilevskis
Dec 17, 2014·International Journal of Epidemiology·Leila D A F Amorim, Jianwen Cai
Dec 17, 2014·Journal of the American Medical Directors Association·Johanna De Almeida MelloAnja Declercq
Apr 19, 2015·BMC Geriatrics·Ruth E HubbardKenneth Rockwood
Aug 12, 2015·Journal of General Internal Medicine·Monika M Safford
Nov 23, 2016·BMC Geriatrics·John N MorrisKnight R Steel
Nov 27, 2016·Journal of the American Medical Directors Association·Leocadio Rodriguez-MañasAlan J Sinclair
May 23, 2017·Age and Ageing·Ruth E HubbardKenneth Rockwood
May 28, 2017·Journal of the American Medical Directors Association·John E MorleyJean Woo
Aug 22, 2016·Public Health Reviews·Brigitte Santos-Eggimann, Nicolas Sirven
Mar 11, 2019·The Lancet. Public Health·Angela Y ChangJoseph L Dieleman
Aug 27, 2019·The Journal of Ambulatory Care Management·Emilia G ThurberGerard Anderson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
MDS

Clinical Trials Mentioned

NCT03883425

Software Mentioned

EuroQoL
Power

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.